American Century Companies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-6,700
Closed -$131K 1505
2015
Q2
$131K Buy
6,700
+1,009
+18% +$19.5K ﹤0.01% 1323
2015
Q1
$103K Buy
+5,691
New +$128K ﹤0.01% 1345

Other funds holding CTIC

American Century Companies's CTIC Position: Q3 2015 in Review

American Century Companies sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2015, closing a stake of 6,700 shares — an estimated $131K sold.

American Century Companies first reported a position in CTIC in Q1 2015 and held it in 2 quarters. The position peaked at $131K in Q2 2015. 86 funds tracked by Wall St. Rank hold CTIC as of Q3 2015.

  • American Century Companies reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2015 after selling out during the quarter.
  • American Century Companies sold 6,700 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2015, an estimated $131K.
  • American Century Companies first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 2 quarters.
  • American Century Companies's CTI BioPharma Corp. (DE) Common Stock position peaked at $131K in Q2 2015.
  • 86 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2015.

Based on American Century Companies's 13F filing for Q3 2015, filed 2 Nov 2015.